To test the biological significance of high ZEB1 expression in conferring resistance to gefitinib in EGFR‐mutant NSCLC cells in vivo, PC9‐ZEB1 and PC9‐mock cells were implanted subcutaneously in NOG mice. This evidence concerns the gene EGFR and non-small cell lung carcinoma.